About J. Molner AS

Company Description

Located in Northern Europe in Estonia, The J. Molner Company's main laboratory was originally founded in 2015 as part of a global pharmaceutical company to accelerate research and development activities. With a focus on sterile injectable and dermatological drugs for both the United States and Canada, our team has developed a GMP certified facility that provides services to pharmaceutical companies looking to grow their pipelines and manage costs by leveraging our capabilities.

Year founded

2020

Served area

Worldwide

Headquarters

Akadeemia tee 21/5, 12618 Tallinn – Estonia

Filings & Publications

Sign up and we will inform you!

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding

1,690,000

IPO

Nov. 10, 2022

Stock exchange(s)

Nasdaq Baltic

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.